Fernandez, Eve F.

HRN: 21-73-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2022
CEFUROXIME 1.5GM (VIAL)
08/07/2022
08/07/2022
IV
1.5g
Once
Pelvic Lap; Prophylaxis Prior To OR
Waiting Final Action 
08/07/2022
CEFUROXIME 1.5GM (VIAL)
08/07/2022
08/08/2022
IV
1.5grams
Q8h X 2 More Doses
SP Pelvic Lap
Waiting Final Action 
08/08/2022
CEFUROXIME 500MG (TAB)
08/08/2022
08/13/2022
PO
500mg
BID
S/p Pelvic Lap
Waiting Final Action 
08/09/2022
AZITHROMYCIN 500MG TABLET (TAB)
08/09/2022
08/14/2022
ORAL
500mg
OD X 5 Days
TC Pneumonia
Waiting Final Action 
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/17/2023
IV
1.5 G
Once PTOR
For Stat CS
Waiting Final Action 
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/18/2023
IV
1.5 G
Q8
S/p Primary CS
Waiting Final Action 
10/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2023
10/18/2023
IV
500 Mg
Q8
S/p Primary CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: